We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01969136
Recruitment Status : Terminated (Study has been suspended due to clinical hold.)
First Posted : October 25, 2013
Last Update Posted : May 3, 2016
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : January 2017
  Estimated Study Completion Date : January 2017